Tazicef - 0409-5083-11 - (CEFTAZIDIME)

Alphabetical Index


Drug Information of Tazicef

Product NDC: 0409-5083
Proprietary Name: Tazicef
Non Proprietary Name: CEFTAZIDIME
Active Ingredient(s): 1    g/1 & nbsp;   CEFTAZIDIME
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Tazicef

Product NDC: 0409-5083
Labeler Name: Hospira, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA062662
Marketing Category: ANDA
Start Marketing Date: 20120305

Package Information of Tazicef

Package NDC: 0409-5083-11
Package Description: 10 VIAL, PIGGYBACK in 1 TRAY (0409-5083-11) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PIGGYBACK

NDC Information of Tazicef

NDC Code 0409-5083-11
Proprietary Name Tazicef
Package Description 10 VIAL, PIGGYBACK in 1 TRAY (0409-5083-11) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PIGGYBACK
Product NDC 0409-5083
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name CEFTAZIDIME
Dosage Form Name INJECTION, POWDER, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20120305
Marketing Category Name ANDA
Labeler Name Hospira, Inc.
Substance Name CEFTAZIDIME
Strength Number 1
Strength Unit g/1
Pharmaceutical Classes Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]

Complete Information of Tazicef


General Information